ClinicalTrials.gg
CompletedNCT03426215Updated Jun 4, 2018

Long-Term Course of Korean Medicine Treatment for Lumbar Disc Herniation

An observational study in Low Back Pain, Sciatica and Intervertebral Disc Displacement, sponsored by Jaseng Medical Foundation. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2018-06-04.

Sponsored by Jaseng Medical Foundation · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
65
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 11 studies in Low Back Pain by Jaseng Medical Foundation — 4 open to participants now, 5 under way, none of them phase 3. Low Back Pain · Jaseng Medical Foundation.

Started
2018
the only one that year
Observational
3 of 11
1 open now
Registered
1st of 11
by date

Among the 11 studies in Low Back Pain by Jaseng Medical Foundation, this one is the only one that started in 2018, is one of 3 observational ones, and was the 1st registered.

By phase

11 studies; the count open now beside each. This study's row is marked.

No phase8 · 3 open
Observationalthis study3 · 1 open

By the year they started

First in 2018; this study’s year is marked. 1 started in 2018.

Size and results

Median enrollment 98 across the 8 interventional studies, 110 across the 3 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.

Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 11 studies in Low Back Pain by Jaseng Medical Foundation, or all of them as a file.
02

Study summary

This observational study will assess the long-term course and effect of Korean medicine treatment in lumbar intervertebral disc herniation patients who received integrative Korean medicine treatment for 24 weeks as part of a previous clinical study.

Read the detailed description

This observational study will assess the long-term course and effect of Korean medicine treatment in lumbar intervertebral disc herniation patients with a main complaint of radiating leg pain who received integrative Korean medicine treatment for 24 weeks at Jaseng Hospital of Korean Medicine (Gangnam main branch) as part of a previous clinical study which was conducted from November, 2006 to April, 2007, and give written informed consent to long-term follow-up assessment at 10 years.

03

Conditions studied

  • Low Back Pain
  • Sciatica
  • Intervertebral Disc Displacement
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Lumbar intervertebral disc herniation patients with a main complaint of radiating leg pain who received integrative Korean medicine treatment for 24 weeks at Jaseng Hospital of Korean Medicine (Gangnam main branch) as part of a previous clinical study which was conducted from November, 2006 to April, 2007.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Lumbar intervertebral disc herniation patients with a main complaint of radiating leg pain who received integrative Korean medicine treatment for 24 weeks at Jaseng Hospital of Korean Medicine (Gangnam main branch) as part of a previous clinical study which was conducted from November, 2006 to April, 2007
  • Patients who give voluntary written to long-term follow-up assessment (quantitative and qualitative questionnaires, and MRI) at 10 years.

Exclusion criteria

Exclusion Criteria:

  • Patients who cannot give voluntary written to this study or answer study questionnaires (e.g. severe psychological disorders)
  • Patients participating in other clinical studies or otherwise deemed unsuitable by the researchers
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
65 participants (actual)
Patient registry
No

Groups and cohorts

  • Ten year follow-up group

    No interventions will be administered (Magnetic Resonance Imaging (MRI) will be administered as an outcome measurement).

    Diagnostic Test: Magnetic Resonance Imaging (MRI)

Interventions

  • Diagnostic testMagnetic Resonance Imaging (MRI)

    Changes in size and severity of the main herniated disc causing radiating pain will be evaluated by radiology specialists and Korean medicine doctors (KMDs) and categorized into three groups (improved, worse or no discernible change) in comparison with the immediate previous MRI to track long-term changes and assess for correlations in subjective clinical symptoms and objective physical evaluation and MRI results.

06

What researchers measure

Primary outcomes

  1. Change in Visual Analogue Scale (VAS) of radiating leg pain

    Visual Analogue Scale (VAS) uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain (minimum score: 0)' and 'worst pain imaginable (maximum score: 100)'. Total scores are recorded in millimeters with a total range of 0-100 millimeters. Higher VAS values represent more severe pain, and a greater change from baseline (If baseline - follow up is a positive value) indicates a better outcome.

    Time frame: Difference from baseline at 10 years

Secondary outcomes

  1. Visual Analogue Scale (VAS) of low back pain

    Visual Analogue Scale (VAS) uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain (minimum score: 0)' and 'worst pain imaginable (maximum score: 100)'. Total scores are recorded in millimeters with a total range of 0-100 millimeters. Higher VAS values represent more severe pain.

    Time frame: Baseline, and 10 years

  2. Visual Analogue Scale (VAS) of radiating leg pain

    Visual Analogue Scale (VAS) uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain (minimum score: 0)' and 'worst pain imaginable (maximum score: 100)'. Total scores are recorded in millimeters with a total range of 0-100 millimeters. Higher VAS values represent more severe pain.

    Time frame: Baseline, and 10 years

  3. Numeric Rating Scale (NRS) of low back pain

    In pain measurement using Numeric Rating Scale (NRS), patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.

    Time frame: Baseline, and 10 years

  4. Numeric Rating Scale (NRS) of radiating leg pain

    In pain measurement using Numeric Rating Scale (NRS), patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 (minimum score) which indicates 'no pain', and 10 (maximum score) which indicates 'worst pain possible'. Higher NRS values represent more severe pain.

    Time frame: Baseline, and 10 years

  5. Oswestry Disability Index (ODI)

    The ODI is a 10-item questionnaire developed to assess level of disability due to low back pain (LBP). Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to LBP.

    Time frame: Baseline, 10 years

  6. 36-Item Short Form Survey (SF-36)

    SF-36 consists of 36 items across 8 domains: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. SF-36 is used to rate functional health and well-being in patients and healthy individuals. Higher scores indicate better HRQoL.

    Time frame: Baseline, 10 years

  7. Patient Global Impression of Change (PGIC)

    PGIC grades the level of subjective improvement into 7 levels (1, very much improved; 2, much improved; 3, slightly improved; 4, no change; 5, slightly worse; 6, much worse; and 7, very much worse).

    Time frame: Baseline, 10 years

  8. Lumbar range of movement (ROM)

    ROM measurements are valid (r=0.97) and reliable (r=0.94), but not highly responsive (effect size=0.1-0.6). If ROM is uncheckable from pain, the angle will be recorded as 0°.

    Time frame: Baseline, 10 years

  9. Straight leg raise (SLR) test

    While SLR measurements are reliable (intraclass correlation coefficient=0.95), they are not very responsive (effect size=0.2). If SLR is uncheckable from pain, the angle will be recorded as 0°.

    Time frame: Baseline, 10 years

  10. Qualitative questionnaire on 10 year course

    The qualitative questionnaire on 10 year course and outcome since receiving integrative Korean medicine treatment used in this study is a 14-item descriptive evaluation encompassing various items (a mixture of short-answer questions, multiple choices, and transcript of essay form answers) on the change before and after treatment over the course of 10 years (e.g. change in perception of surgery and non-surgical treatment, change in everyday life or habits, and treatment recommendation to others).

    Time frame: 10 years

  11. Medical history

    Physicians will rate the causal relationship of each treatment from the previous clinical study with the patient's medical history potentially associated with treatment on a 6-point scale (1, definitely related; 2, probably related; 3, possibly related; 4, probably not related; 5, definitely not related; and 6, unknown), and classify all medical history potentially associated with treatment with the Spilker classification, which has 3 grades (1, mild: no intervention needed and does not greatly impede normal activity (function) of patient; 2, moderate: significantly impedes normal activity (function) of patient, and may need intervention, with subsequent resolution; 3, severe: severe adverse event needing intensive intervention, leaving sequela).

    Time frame: 10 years

  12. Adverse events

    Adverse events potentially associated with MRI will be assessed.

    Time frame: 10 years

07

Study locations

1 site
  • Jaseng Hospital of Korean Medicine
    Seoul, 06110, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03426215
Lead sponsor
Jaseng Medical Foundation
Responsible party
In-Hyuk Ha, KMD (Director, Jaseng Medical Foundation) — Principal investigator
First posted
Feb 8, 2018
Start date
Mar 10, 2018
Primary completion
Apr 28, 2018
Completion
Apr 28, 2018
Last update
Jun 4, 2018

Study contacts

Me-riong Kim, KMD, M.Sc.
principal investigator · Jaseng Medical Foundation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion